Inhaled Insulin
The Food and Drug Administration has approved an inhaled insulin for adults with type 1 or type 2 diabetes. Called Exubera, the drug is a powder form of recombinant human insulin that’s inhaled orally. More than 5 million Americans with diabetes inject insulin. With the approval of inhaled insulin, they have the first new delivery option since insulin was discovered in the 1920s.
In clinical trials, Exubera acheived peak insulin levels more quickly than regular insulin given by injection (49 minutes versus 105 minutes). In patients with type 1 diabetes, it may be added to long-acting insulin as a replacement for short-acting insulin taken with meals. In type 2 diabetes, it may be used alone, with an oral antidiabetic drug, or with long-acting insulin.
NDHnow.com - News Capsules - Inhaled Insulin